Mersana Therapeutics Presents Preclinical Data Further Demonstrating Differentiating Aspects of Its ADC Platform Technology at AACR 2018 by GlobeNewsWire | Apr 17, 2018 | Globe Newswire Detailed Characterization of Unique DolaLock Technology Enhancements to Drug Efficacy and Tolerability
